Hope for Mesothelioma Patients- The Drug “Ranpirnase”
My mesothelioma clients and their families who have dealt with this devastating disease all hope that someday there will be a cure for this aggressive cancer. As a mesothelioma lawyer, I often remind my clients that research is being conducted every day around the country, indeed around the world, in which scientists are searching for a cure for mesothelioma and other forms of cancer. I urge my client to never lose hope.
I know that researchers are hard at work discovering new ways to diagnose and treat mesothelioma. Whenever I read about new medical advances, I find myself being grateful to these dedicated scientists. I commend researchers like Masaki Nasu, whom I just read about, for his hard work and efforts to find a better quality of life for mesothelioma victims.
Research Shows Drug Inhibits Growth of Mesothelioma Tumor
Masaki Nasu is a young researcher recently profiled in Innovations, the University of Hawai’i Cancer Center’s newsletter. I read this article with great interest and excitement. Nasu has been working with a drug called Ranpirnase (Onconase) to treat malignant mesothelioma. Dr. Nasu’s findings seem to show that Ranpirnase does inhibit mesothelioma tumor growth in his cell culture experiments.
A postdoctoral candidate, Dr. Nasu will be the lead author of a paper that has been accepted for publication in the journal Genes & Cancer. According to Innovations, his manuscript is called “Ranpirnase interferes with NF-kB pathway and MMP9 activity, inhibiting Malignant Mesothelioma cell invasiveness and xenografts growth.”
Research Offers Hope, Promise, and Someday, A Cure for Mesothelioma
Research such as this provides great hope and promise for the treatment and someday a cure for mesothelioma. I have been representing mesothelioma clients and their families for 33 years. It would be wonderful to see a successful treatment regimen developed in my lifetime for people being diagnosed with this devastating disease, malignant mesothelioma.